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INTRODUCTION
The regulation of the secretion of fluid and proteins from
salivary glands is usually thought to be solely the result of
nervous activity (1, 2). In recent years, however, some
hormones/hormone analogues have been found to cause the
exocytosis of acinar granules and to increase the protein content
of the saliva without affecting the flow. In the rat, pentagastrin,
which has the same biological activity as native gastrin (3),
cholecystokinin and melatonin cause the prompt release of
acinar amylase from the parotid gland upon intravenous
administration (4-6). In pieces of human parotid gland tissue
exposed to pentagastrin, exocytotic "dynamic" events have been
demonstrated at both light- and electron-microscopic levels,
indicating secretory activity, and, in addition, the protein
concentration of the tissue incubate has been found to increase
(7). Whereas gastrin and cholecystokinin are well-known
gastrointestinal hormones, melatonin is usually associated with
the pineal gland. Nevertheless, by far the largest source of
melatonin in the body is the mucosa of the gastrointestinal tract,
where it is synthesised by the enterochromaffin cells (8, 9).
Animal experiments show that the melatonin concentration in
the peripheral blood, and in the gastrointestinal tract, increases in
response to food intake (9).
It is possible that, in human salivary glands, circulating
melatonin, released in connection with a meal, acts in concert
with autonomic neurotransmitters and some gastrointestinal
hormones to influence the salivary response. Considering that
usually only a few, small pieces of surgical specimens from a
human salivary gland are available for studies and that the
number of contributing patients is restricted, we applied our in
vitro technique to reveal morphological changes reflecting
secretion (10-13) and focused on the effect of a high single
concentration of melatonin to establish whether, if at all, the
secretory cells would respond to melatonin. Our working
hypothesis of a secretory effect by melatonin was tested on the
acinar serous cells of the parotid gland tissue. Interest focused in
particular on the membrane of the intercellular canaliculi, as a
large part of protein secretion takes place at this site (11). Here,
ultrastructural phenomena reflecting anchored secretory
granules (visible as protrusions by scanning electron
microscopy), recycling membranes and/or vesicles (visible as
microbuds), and cytoskeletal re-arrangements allowing secretory
granules to reach the luminal membrane (visible as the collapse
of microvilli) are all used as indicators of secretory activity (7,
14). As the results showed that melatonin does in fact induce
exocytotic events, we further investigated whether the effect of
melatonin was affected by the presence of the melatonin receptor
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antagonist, luzindole, previously found to be effective in
inhibiting the melatonin-evoked protein secretion in rats (6).
MATERIALS AND METHODS
Fragments of human parotid glands were obtained during
orofacial surgery from 11 patients (6 males and 5 females) aged
40 – 73 years. The tissues under study came from non-irradiated
glands and appeared normal under light microscopy. The present
study conforms with the principles outlined in the Declaration of
Helsinki. Written informed consent was obtained from each
patient and permission was granted by the local ethics committee
(ASL 8, Cagliari, Italy). The aspect of any gender or age
differences with respect to gland morphology was not taken into
account.
Tissue preparation
Samples were immediately cut into 1 mm3 pieces and put
into 10 ml of oxygenated inorganic medium (NaCl 79 mM, KCl
4.9 mM, MgCl2 1.2 mM, CaCl2 1 mM, TRIS 16 mM, D-glucose
5 mM, NaHCO3 44 mM; 13) kept at 37°C. The bath
concentration of melatonin, 1 mM, was chosen from the
literature (15, 16) and found to give distinct and reproducible
observations. After 15 minutes of exposure to the hormone, the
fragments of the glands were removed. To test the effect of
luzindole (100 µM), the inhibitor was added to the medium five
minutes before melatonin. Specimens incubated in the same
medium, and under the same time protocol, but in the absence of
the hormone (and luzindole) served as controls.
After stimulation, treated and control specimens were fixed
in a mixture of 1% paraformaldehyde and 1.25% glutaraldehyde
in 0.15 M cacodylate buffer (pH 7.2), for two hours at room
temperature, embedded in epoxy resin and treated for
transmission electron microscopy (TEM; 17). Semi-thin sections
were stained for light microscopy (LM) with toluidine blue and
examined in a Leica DMR HC. Ultra-thin sections were
observed with a Jeol 100S TEM operated at 80 kV.
For high resolution scanning electron microscopy
(HRSEM), some fragments were fixed in a mixture of 0.5%
glutaraldehyde and 0.5% paraformaldehyde in 0.1 M cacodylate
buffer (pH 7.2) for 15 minutes at room temperature. After rinsing
in a phosphate buffered saline (PBS), specimens were cut into
150 µm slices and subjected to our variant (18, 19) of the OsO4
maceration method. To view the cytoplasmic side of the
membrane, we used a rotating agitator during rinsing to remove
all cellular organelles. In order to highlight HRSEM images,
slices of tissue were sputtered with platinum (2 nm thickness).
Observations were made using a Hitachi S4000 FEG HRSEM
operated at 15 – 20 kV.
Drugs
All drugs were purchased from Sigma (St. Louis, MO,
USA).
Statistical analysis
To evaluate secretion by morphological changes, in HRSEM
images of the cytoplasmic side of intercellular canaliculi, the
mean number of microvilli, microbuds and protrusions per µm2
of membrane (density) was calculated (7, 14). One hundred and
fifty photographs were used for calculations and each gland
contributed 12 – 15 photos. Statistical differences between
experiments were determined by the Kruskal-Wallis test with the
Dunn post-test. All the data were expressed as means ± S.E.M.
and represented in figures as percentages. The significance level
was set at P < 0.05. Images were obtained by Quartz PCI (Quartz
Imaging, Vancouver, Canada). Measurements and statistical
analyses were carried out with Image Tool for Windows
(University of Texas Health Science Center in San Antonio),
Microsoft Excel 2003 and Graphpad for Windows (GraphPad
Software, San Diego, CA, USA).
RESULTS
In the specimens serving as controls (Fig. 1), by light
microscopy (LM) and transmission electron microscopy (TEM),
both acinar and canalicular lumina were restricted and the serous
cells were full of secretory granules. No profiles of exocytosis
were seen.
By LM (Fig. 1) and TEM (Fig. 2), specimens exposed to
melatonin (1 mM) displayed dilated acinar and canalicular
lumina. Although they were still well loaded with granules, the
serous cells appeared to be less packed with granules after
melatonin. Furthermore, the serous cells showed frequently
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Fig. 1. Light microscope (LM) images. (a) Control parotid tissue, and tissues exposed to (b) just melatonin (1 mM) or (c) melatonin (1 mM)
in the presence of luzindole (100 µM). After treatment with just melatonin (b) lumina as well as intercellular canaliculi are dilated,
exocytotic profiles are present, and the acinar cells seem less packed with granules. Circle: intercellular canaliculi; Asterisk: exocytotic
profiles; (#) adipocytes. Bar: 10 µm.
exocytotic profiles which, by TEM, were visible as Ω-shaped
profiles connected to the lumen with the size of a single granule.
By high resolution scanning electron microscopy (HRSEM),
in the specimens subjected to the melatonin treatment (Fig. 3),
the canaliculi showed, on the cytoplasmic side of their
membrane, large protrusions (related to anchored granules) and
some small microbuds (80 – 120 nm thickness, related to
vesicles and/or recycling membranes) located among the bases
of microvilli, visible as holes. A few microbuds were frequently
observed on the protrusions. Morphometric calculations related
to the µm2 of membrane showed that the protrusion density was
446% higher (Fig. 4) in the melatonin-exposed specimens than
in the controls (0.71 ± 0.08 versus 0.13 ± 0.04, P < 0.001). The
density of microvilli in the presence of melatonin was 57%
lower than that in its absence (11.3 ± 1.2 versus 26.0 ± 1.8, P <
0.001). With respect to the density of the microbuds, it was
140% higher in the melatonin-exposed specimens than in the
controls (10.8 ± 0.8 versus 4.5 ± 0.6, P < 0.001). The response to
melatonin in the presence of luzindole, as compared to that in its
absence, was markedly diminished (P < 0.001, protrusion
density 0.28 ± 0.05, microvilli density 21.6 ± 1.3 and microbud
density 5.8 ± 0.6) and, in fact, not statistically significantly
different from that of control specimens (Fig. 4). Moreover, the
luminal dilatation was absent and the exocytotic profiles were
few in number (Figs. 1c, 2c, 3d).
DISCUSSION
The present in vitro approach revealed morphological
changes in the surgical specimens of human parotid glands
exposed to melatonin, which are associated with secretory
activity. Both the acinar and the intercellular canalicular lumina
were dilated and exocytotic profiles of granules were frequently
observed. With the emphasis on the cytoplasmic aspect of the
canaliculi membrane, morphometric assessments of the
melatonin-exposed parotid tissues, compared with the control
specimens, showed a conspicuous increase (446%) in the density
of protrusions, reflecting anchored granules ready for secretion
by the major regulated pathway (20, 21), a decrease (57%) in the
density of microvilli, reflecting the cytoskeletal re-arrangement
associated with the major regulated secretory pathway and
permitting granules to be translocated to the luminal membrane
(13, 22), and an increase (140%) in the density of microbuds,
reflecting recycling membranes (related to endocytosis) and/or
small micro-exocytotic events associated with constitutive and
constitutive-like secretion (20, 21, 23). At the same time, the
widening of the lumina may indicate some water secretion,
while acinar vacuolisation, associated with a rich fluid secretion
like that occurring in response to muscarinic agonists, was
lacking (7, 22). The overall response to melatonin is reminiscent
of that to the β-adrenoceptor agonist, isoprenaline, and to
pentagastrin, agonists which preferentially cause the release of
proteins with only little or no fluid secretion (7, 22, 24).
Melatonin exerts both receptor-dependent and receptor-
independent actions. The melatonin receptors, MT1 and MT2,
which belong to the family of cell membrane G-protein receptors,
are localised at various sites in the central nervous system and in
numerous, if not all, peripheral tissues. The intracellular signalling
systems responding to the activation of the melatonin receptors
appear to be tissue specific and may include adenyl cyclase, guanyl
cyclase, phospholipases C and A2 and potassium and calcium
channels (25). Receptor-independent phenomena of melatonin are
the free radical scavenging action, as well as the mobilisation of
anti-oxidative enzymes (26, 27). Human parotid acinar cells show
diffuse cytoplasmic immunoreactivity to both MT1 and MT2
receptors, as judged by light microscopy (28-30). By electron
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Fig. 2. Transmission electron microscopy (TEM). (a) Control
parotid tissue, and tissues exposed to (b) just melatonin (1
mM) or (c) melatonin (1 mM) in the presence of luzindole
(100 µM). Lumina are dilated and several exocytotic profiles
are visible after just melatonin; inset: transverse-sectioned
intercellular canaliculi with exocytotic profiles clearly
connected to them. In control tissue as well as in tissue
exposed to melatonin + luzindole, no exocytotic profiles of
secretory granules are observed. The difference in staining
intensity between the granules of the three specimens is
ascribed to a difference in staining time. G: secretory
granules; L: lumina; N: nuclei. Asterisks: exocytotic profiles.
Arrows: microvilli. Bar: 1 µm.
microscopy, using the immunogold staining technique, the
distribution of the two subtypes of receptor was localised in both
the cell membranes and the subcellular structures. In comparison
with the MT1 receptors, the reactivity to the MT2 receptors was
850
Fig. 4. Percentage comparisons. Effects of 1 mM of melatonin (Mel) or 1 mM of melatonin combined with 100 µM of luzindole (Luz +
Mel) on the density of microvilli, microbuds and protrusions. Mean density of the control values was set at 100%. The columns represent
means and bars + S.E.M. *** P<0.001, statistically significant with respect to control. N.S.: not significant compared with control.
Fig. 3. High resolution scanning electron microscopy (HRSEM) images. (a) Control parotid tissue, and tissues exposed to (b and c) just
melatonin (1 mM) or (d) melatonin (1 mM) in the presence of luzindole (100 µM). As seen from the cytoplasmic side of the intercellular
canaliculi, just melatonin (b and c) resulted in the appearance of protrusions and microbuds. In control and melatonin + luzindole exposed
tissues none or only few protrusions are visible. Microvilli are represented by holes. Arrows: microvilli. Arrowheads: microbuds. Asterisks:
protrusions. Bar: 1 µm.
weaker and less frequently observed (30). Evidently, the exocytotic
events presently observed involved melatonin receptors, as judged
by using luzindole. Although luzindole is usually regarded as an
MT2-receptor blocker, it also displays a certain affinity for the
MT1 receptor (31, 32). For this reason, the possibility cannot be
excluded that the present exocytotic events also involved the
stimulation of the MT1 receptors to some extent. Albeit not of
statistical significance, the figures for the protrusion density of the
specimens exposed to melatonin combined with luzindole were
higher than the corresponding figures for the control specimens,
which may be related to the concentration with respect to agonist
and antagonist, as discussed in some other in vitro preparations
testing the two substances (16, 33, 34). It should, however, be
mentioned that receptor-independent effects are reported in
response to high doses of melatonin, mainly in connection with its
anti-oxidant activity (35, 36). The anti-inflammatory action of
melatonin demonstrated in the rat parotid gland may be one such
example (37).
Interestingly, melatonin at low concentrations inhibits the in
vitro release of vasopressin from the rat hypothalamo-
neurohypophysial system by acting on MT1 receptors. In contrast,
a high pharmacological concentration of melatonin stimulates the
release of vasopressin through mechanisms independent of MT1
and MT2 receptors, since the secretory response to melatonin is
unaffected by luzindole or the MT2 receptor selective antagonist
4-P-PDOT (38). The fact that, in the current in vitro preparation,
luzindole markedly affected the melatonin-evoked response
makes it likely that melatonin would also act directly on the
melatonin receptors of salivary secretory cells in humans in vivo.
In the rat parotid gland, melatonin causes the in vivo secretion of
amylase/proteins, most probably by direct action on the melatonin
receptors of the acinar cells (6). In contrast, melatonin evokes
duodenal bicarbonate secretion (39) and pancreatic amylase
secretion (40) indirectly, by acting via enteric nerves (bicarbonate
secretion) or vago-vagal reflexes (amylase secretion).
Large variations in the in vivo concentration of melatonin
can be anticipated at the receptor sites between various effector
organs (36, 41). Although the present in vitro concentration of
melatonin - the same as in some other in vitro studies (15, 16) -
provided reproducible data, indicating a potential role for
melatonin in the protein secretion of the acinar cells of the
human parotid gland, it was much higher than the concentration
that can be anticipated in physiological conditions (42).
Consequently, it is not possible to determine from the present
experiment whether melatonin within physiological
concentrations would affect salivary protein secretion. In
physiological conditions, melatonin is likely to interact
positively with both traditional and non-traditional autonomic
transmitters, as well as with gastrointestinal hormones, like
gastrin and cholecystokinin, to achieve the most purposeful
glandular response. For this reason, the blood level of melatonin
needed to contribute to glandular secretory activity can be
expected to be lower than the blood level of melatonin necessary
to elicit the corresponding response when acting alone.
Furthermore, it is important to consider the influence of the
circadian rhythm of blood melatonin mainly associated with
pineal gland secretion (41), with low blood levels of melatonin
during the day and about ten times higher blood levels of
melatonin during the night, with a plateau at 02 – 05 h (e.g. 42),
combined with the fact that food intake in humans usually occurs
during the day in contrast to nocturnal laboratory animals like
rodents. In addition, as it has been suggested that a melatonin
synthesis occurs in salivary duct cells (43), a paracrine secretion
of melatonin that acts on the acinar cells, as suggested by Acuna-
Castroviejo et al. (36), may have to be taken into account when
considering the physiological concentration of melatonin
required to contribute to salivary secretory phenomena.
In salivary glands, exocytosis and protein secretion with
little or no accompanying fluid secretion, like that in response to
isoprenaline and vasoactive intestinal peptide, for example, is
associated with the mobilisation of the intracellular cyclic AMP
pathway (44, 45). Protein secretion, in response to these
agonists, as well as to pentagastrin and melatonin, is partly
dependent on the generation of nitric oxide by the activity of NO
synthase of the neuronal type but of parenchymal origin, as
shown in the rat parotid gland (5, 6, 46). An intracellular
interaction between the NO/cyclic GMP and cyclic AMP
pathways has been suggested (47). The intracellular pathways
that are mobilised in the acinar cells of salivary glands in
response to gastrointestinal hormones/hormone analogues, such
as melatonin and pentagastrin, remain to be elucidated.
Based on previous in vivo studies of the rat parotid gland (4-6),
it has been suggested that the secretion of saliva in response to food
intake is regulated, as is the case for many digestive glands, not
only by nerves but also by hormones and, from various locations,
by the traditional cephalic phase and, in addition, by a gastric phase
(gastrin) and an intestinal phase (melatonin and also
cholecystokinin acting, like gastrin, via cholecystokinin-A
receptors). The currently demonstrated exocytosis in the human
parotid acinar cells, combined with the previously demonstrated
pentagastrin-evoked exocytosis and protein secretion in this type of
human gland tissue (7), is in agreement with an idea of this kind.
In addition, the presence of melatonin receptors in the duct cells of
human salivary glands may suggest a regulatory role for melatonin
in electrolyte secretion, as pointed out by Arias-Santiago et al. (28).
In analogy with data obtained on the rat parotid gland, the three
hormones are, moreover, potential contributors to the synthesis of
salivary secretory proteins in human salivary glands (48, 49). In
future experiments, proteomics applied to the saliva or to the gland
tissue incubate will probably reveal how hormones, including
melatonin, by their actions, influence the protein/peptide profile of
the saliva (50). It would, for example, be of interest to investigate
whether, in any way, the protein composition of the salivary
secretion follows the circadian rhythm of melatonin or whether it
is influenced by the intake of melatonin as medication (51).
Studying the impact of gastrointestinal hormones on salivary
gland functions may offer new approaches to the treatment of
salivary gland dysfunctions and dry mouth. In addition, via its
melatonin receptors, the salivary gland may actively take up,
transport and store circulating melatonin in the secretory granules
(30, Isola M, unpublished observations). The elevated blood levels
of melatonin during the night may hypothetically serve to load the
salivary glands, as has been suggested for the intestinal tract (52).
Once secreted into the oral cavity, melatonin may exert a number
of beneficial effects on oral health (53). Interestingly, both L-
tryptophan as a source of endogenous melatonin and exogenous
melatonin have been found to exert oesophagoprotective effects in
an animal model focusing on non-erosive oesophageal lesions (54).
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